Health

Wipro GE Healthcare on Tuesday said it will invest over Rs 8,000 crore in India over the next five years

According to the projections, the burden of female breast cancer in India in 2025 is expected to be 5.6 million

The trials are carried out by Bharat Biotech in close collaboration with Biofabri. Trials to evaluate the safety and immunogenicity

London: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie’s “guided missile” cancer

E lon Musk’s brain-chip startup Neuralink livestreamed on Wednesday its first patient implanted with a chip playing online chess. Noland

New Delhi: Cardiologists are advocating for additional research on the drug lecanemab that can add to the limited safety data,

<img class="unveil" loading="eager" src="https://health.economictimes.indiatimes.com/Themes/Release/images/responsive/ethealthworld-default.jpg" data-src="https://etimg.etb2bimg.com/photo/108607755.cms" captionrendered="1" alt=" REUTERS/Amit Dave/File Photo “>REUTERS/Amit Dave/File Photo NEW DELHI: Supreme Court on Tuesday issued

Indore: The export of pharmaceutical products from Madhya Pradesh has seen a significant increase in the ongoing fiscal year with

Sapporo: A new study has discovered a potential therapy target for immune-related conditions such as multiple sclerosis and asthma. A

The panel consists of three core members: secretary, department of pharmaceuticals; senior economic advisor, department of pharmaceuticals; and chairman of